Madrigal Pharmaceuticals Inc (MDGL)
211.73
+0.75
(+0.36%)
USD |
NASDAQ |
May 15, 16:00
211.71
-0.02
(-0.01%)
After-Hours: 20:00
Madrigal Pharmaceuticals Market Cap: 4.512B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 15, 2024 | 4.512B |
| May 14, 2024 | 4.496B |
| May 13, 2024 | 4.504B |
| May 10, 2024 | 4.374B |
| May 09, 2024 | 4.410B |
| May 08, 2024 | 4.434B |
| May 07, 2024 | 4.645B |
| May 06, 2024 | 5.020B |
| May 03, 2024 | 4.898B |
| May 02, 2024 | 4.599B |
| May 01, 2024 | 4.482B |
| April 30, 2024 | 4.342B |
| April 29, 2024 | 4.280B |
| April 26, 2024 | 4.115B |
| April 25, 2024 | 4.137B |
| April 24, 2024 | 4.356B |
| April 23, 2024 | 4.648B |
| April 22, 2024 | 4.544B |
| April 19, 2024 | 4.447B |
| April 18, 2024 | 4.661B |
| April 17, 2024 | 4.789B |
| April 16, 2024 | 4.886B |
| April 15, 2024 | 4.852B |
| April 12, 2024 | 4.962B |
| April 11, 2024 | 5.144B |
| Date | Value |
|---|---|
| April 10, 2024 | 5.131B |
| April 09, 2024 | 5.229B |
| April 08, 2024 | 5.214B |
| April 05, 2024 | 5.097B |
| April 04, 2024 | 5.064B |
| April 03, 2024 | 5.143B |
| April 02, 2024 | 5.128B |
| April 01, 2024 | 5.290B |
| March 28, 2024 | 5.508B |
| March 27, 2024 | 5.338B |
| March 26, 2024 | 5.107B |
| March 25, 2024 | 5.107B |
| March 22, 2024 | 5.119B |
| March 21, 2024 | 5.265B |
| March 20, 2024 | 5.153B |
| March 19, 2024 | 5.286B |
| March 18, 2024 | 5.636B |
| March 15, 2024 | 5.380B |
| March 14, 2024 | 4.846B |
| March 13, 2024 | 5.432B |
| March 12, 2024 | 5.226B |
| March 11, 2024 | 5.176B |
| March 08, 2024 | 5.080B |
| March 07, 2024 | 4.995B |
| March 06, 2024 | 5.121B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
927.76M
Minimum
Apr 03 2020
5.704B
Maximum
Apr 28 2023
2.303B
Average
1.653B
Median
Nov 12 2019
Market Cap Benchmarks
| Viking Therapeutics Inc | 8.602B |
| Eli Lilly and Co | 747.99B |
| Akero Therapeutics Inc | 1.457B |
| 89bio Inc | 905.13M |
| Geron Corp | 2.313B |
Market Cap Related Metrics
| PS Ratio | 615.15 |
| Price to Book Value | 5.304 |
| Price | 211.73 |
| Earnings Yield | -10.92% |